Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CHF 6467

Next Previous
Drug Profile

CHF 6467

Alternative Names: CHF-6467

Latest Information Update: 15 Sep 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Chiesi Farmaceutici
  • Class Foot disorder therapies; Nerve growth factors
  • Mechanism of Action Nerve growth factor receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Diabetic foot ulcer

Most Recent Events

  • 09 Sep 2025 Chiesi Farmaceutici plans a phase I trial Pharmacokinetics trial for healthy volunteers in Bulgaria (Intranasal) in September 2025 (NCT07163182)
  • 20 Feb 2023 Benedetto Falsini plans phase II NGF-OPG trial in Optic nerve glioma (In adolescents, In children, In adults) in Italy in March 2023 (Ophthalmic, Drops) (NCT05733572) (CHF6467-OPG)
  • 28 Nov 2021 No recent reports of development identified for phase-I development in Diabetic-foot-ulcer in Bulgaria (Topical)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top